EPISODE · Oct 5, 2020 · 1 MIN
October 5, 2020 Biz in 60
from Business in 60 Seconds · host TRT World
Turkey's inflation eases marginally to 11.75% in September Turkey's annual inflation edged down slightly in September as slowing price gains in housing and apparels offset the impact of a weaker lira. Consumer prices rose 11-point-75 percent last month, following an 11-point-77 percent reading in August. Under a new economic programme unveiled last week, Turkey is aiming for a 10-and- a-half percent inflation rate by the end of the year. Italian payment providers Nexi, SIA agree on $17.6B merger Italy's biggest payment provider, Nexi, has agreed to buy domestic rival, SIA, in a 17-point-6 billion dollar merger. The deal would create one of Europe's largest fintech groups, with combined annual revenues of more than 2-billion- dollars. Nexi will have a 70 -percent stake in the merged company, while SIA will hold the remaining 30-percent. Bristol Myers Squibb to buy MyoKardia for $13B US drug-maker Bristol Myers Squibb has agreed to buy MyoKardia for around 13-billion- dollars. The acquisition will bolster Bristol Myers' heart disease therapies by gaining access to MyoKardia's promising drug, mava- camten. Bristol Myers' latest deal comes after it paid 74-billion- dollars to buy the cancer drug maker, Celgene, last year.. marking the industry's biggest merger.
What this episode covers
Turkey's inflation eases marginally to 11.75% in September Turkey's annual inflation edged down slightly in September as slowing price gains in housing and apparels offset the impact of a weaker lira. Consumer prices rose 11-point-75 percent last month, following an 11-point-77 percent reading in August. Under a new economic programme unveiled last week, Turkey is aiming for a 10-and- a-half percent inflation rate by the end of the year. Italian payment providers Nexi, SIA agree on $17.6B merger Italy's biggest payment provider, Nexi, has agreed to buy domestic rival, SIA, in a 17-point-6 billion dollar merger. The deal would create one of Europe's largest fintech groups, with combined annual revenues of more than 2-billion- dollars. Nexi will have a 70 -percent stake in the merged company, while SIA will hold the remaining 30-percent. Bristol Myers Squibb to buy MyoKardia for $13B US drug-maker Bristol Myers Squibb has agreed to buy MyoKardia for around 13-billion- dollars. The acquisition will bolster Bristol Myers' heart disease therapies by gaining access to MyoKardia's promising drug, mava- camten. Bristol Myers' latest deal comes after it paid 74-billion- dollars to buy the cancer drug maker, Celgene, last year.. marking the industry's biggest merger.
NOW PLAYING
October 5, 2020 Biz in 60
No transcript for this episode yet
Similar Episodes
Mar 19, 2026 ·34m
Feb 18, 2026 ·11m
Feb 11, 2026 ·45m
Nov 12, 2025 ·35m
Oct 17, 2025 ·40m